Skip to main content
Top
Published in: Abdominal Radiology 1/2024

03-10-2023 | Gallbladder Cancer | Hepatobiliary

Radiomics-based machine learning and deep learning to predict serosal involvement in gallbladder cancer

Authors: Shengnan Zhou, Shaoqi Han, Weijie Chen, Xuesong Bai, Weidong Pan, Xianlin Han, Xiaodong He

Published in: Abdominal Radiology | Issue 1/2024

Login to get access

Abstract

Objective

Our study aimed to determine whether radiomics models based on contrast-enhanced computed tomography (CECT) have considerable ability to predict serosal involvement in gallbladder cancer (GBC) patients.

Materials and methods

A total of 152 patients diagnosed with GBC were retrospectively enrolled and divided into the serosal involvement group and no serosal involvement group according to paraffin pathology results. The regions of interest (ROIs) in the lesion on all CT images were drawn by two radiologists using ITK-SNAP software (version 3.8.0). A total of 412 features were extracted from the CT images of each patient. The Mann‒Whitney U test was applied to identify features with significant differences between groups. Seven machine learning algorithms and a deep learning model based on fully connected neural networks (f-CNNs) were used for radiomics model construction. The prediction efficacy of the models was evaluated using receiver operating characteristic (ROC) curve analysis.

Results

Through the Mann‒Whitney U test, 75 of the 412 features extracted from the CT images of patients were significantly different between groups (P < 0.05). Among all the algorithms, logistic regression achieved the highest performance with an area under the curve (AUC) of 0.944 (sensitivity 0.889, specificity 0.8); the f-CNN deep learning model had an AUC of 0.916, and the model showed high predictive power for serosal involvement, with a sensitivity of 0.733 and a specificity of 0.801.

Conclusion

Radiomics models based on features derived from CECT showed convincing performances in predicting serosal involvement in GBC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schmidt MA, Marcano-Bonilla L, Roberts LR. Gallbladder cancer: epidemiology and genetic risk associations. Chin Clin Oncol. 2019;8(4):31.CrossRefPubMed Schmidt MA, Marcano-Bonilla L, Roberts LR. Gallbladder cancer: epidemiology and genetic risk associations. Chin Clin Oncol. 2019;8(4):31.CrossRefPubMed
2.
go back to reference Jiang W, Zhao B, Li Y, Qi D, Wang D. Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision. BMC Cancer. 2020;20(1):1129.CrossRefPubMedPubMedCentral Jiang W, Zhao B, Li Y, Qi D, Wang D. Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision. BMC Cancer. 2020;20(1):1129.CrossRefPubMedPubMedCentral
3.
go back to reference Feo CF, Ginesu GC, Fancellu A, Perra T, Ninniri C, Deiana G, et al. Current management of incidental gallbladder cancer: A review. Int J Surg. 2022;98:106234.CrossRefPubMed Feo CF, Ginesu GC, Fancellu A, Perra T, Ninniri C, Deiana G, et al. Current management of incidental gallbladder cancer: A review. Int J Surg. 2022;98:106234.CrossRefPubMed
4.
go back to reference Pilgrim CH, Groeschl RT, Turaga KK, Gamblin TC. Key factors influencing prognosis in relation to gallbladder cancer. Dig Dis Sci. 2013;58(9):2455-62.CrossRefPubMed Pilgrim CH, Groeschl RT, Turaga KK, Gamblin TC. Key factors influencing prognosis in relation to gallbladder cancer. Dig Dis Sci. 2013;58(9):2455-62.CrossRefPubMed
5.
go back to reference Mahul B. Amin SBE, Frederick L. Greene, David R. Byrd, Robert K. Brookland, Mary Kay Washington, Jeffrey E. Gershenwald, Carolyn C. Compton, Kenneth R. Hess, Daniel C. AJCC Cancer Staging Manual. 8th ed. New York: Springer. 2017. Mahul B. Amin SBE, Frederick L. Greene, David R. Byrd, Robert K. Brookland, Mary Kay Washington, Jeffrey E. Gershenwald, Carolyn C. Compton, Kenneth R. Hess, Daniel C. AJCC Cancer Staging Manual. 8th ed. New York: Springer. 2017.
6.
go back to reference Cherkassky L, D'Angelica M. Gallbladder Cancer: Managing the Incidental Diagnosis. Surg Oncol Clin N Am. 2019;28(4):619-30.CrossRefPubMed Cherkassky L, D'Angelica M. Gallbladder Cancer: Managing the Incidental Diagnosis. Surg Oncol Clin N Am. 2019;28(4):619-30.CrossRefPubMed
7.
go back to reference Gupta P, Kumar M, Sharma V, Dutta U, Sandhu MS. Evaluation of gallbladder wall thickening: a multimodality imaging approach. Expert Rev Gastroenterol Hepatol. 2020;14(6):463-73.CrossRefPubMed Gupta P, Kumar M, Sharma V, Dutta U, Sandhu MS. Evaluation of gallbladder wall thickening: a multimodality imaging approach. Expert Rev Gastroenterol Hepatol. 2020;14(6):463-73.CrossRefPubMed
8.
go back to reference Sung YS, Park B, Park HJ, Lee SS. Radiomics and deep learning in liver diseases. J Gastroenterol Hepatol. 2021;36(3):561-8.CrossRefPubMed Sung YS, Park B, Park HJ, Lee SS. Radiomics and deep learning in liver diseases. J Gastroenterol Hepatol. 2021;36(3):561-8.CrossRefPubMed
9.
go back to reference Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, et al. Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin. 2019;69(2):127-57.CrossRefPubMedPubMedCentral Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, et al. Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin. 2019;69(2):127-57.CrossRefPubMedPubMedCentral
11.
go back to reference Hatt M, Le Rest CC, Tixier F, Badic B, Schick U, Visvikis D. Radiomics: Data Are Also Images. J Nucl Med. 2019;60(Suppl 2):38S-44S.CrossRefPubMed Hatt M, Le Rest CC, Tixier F, Badic B, Schick U, Visvikis D. Radiomics: Data Are Also Images. J Nucl Med. 2019;60(Suppl 2):38S-44S.CrossRefPubMed
12.
go back to reference Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749-62.CrossRefPubMed Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749-62.CrossRefPubMed
13.
14.
go back to reference Conti A, Duggento A, Indovina I, Guerrisi M, Toschi N. Radiomics in breast cancer classification and prediction. Semin Cancer Biol. 2021;72:238-50.CrossRefPubMed Conti A, Duggento A, Indovina I, Guerrisi M, Toschi N. Radiomics in breast cancer classification and prediction. Semin Cancer Biol. 2021;72:238-50.CrossRefPubMed
15.
go back to reference Ji GW, Zhang YD, Zhang H, Zhu FP, Wang K, Xia YX, et al. Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes. Radiology. 2019;290(1):90-8.CrossRefPubMed Ji GW, Zhang YD, Zhang H, Zhu FP, Wang K, Xia YX, et al. Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes. Radiology. 2019;290(1):90-8.CrossRefPubMed
16.
go back to reference Tang Y, Yang CM, Su S, Wang WJ, Fan LP, Shu J. Machine learning-based Radiomics analysis for differentiation degree and lymphatic node metastasis of extrahepatic cholangiocarcinoma. BMC Cancer. 2021;21(1):1268.CrossRefPubMedPubMedCentral Tang Y, Yang CM, Su S, Wang WJ, Fan LP, Shu J. Machine learning-based Radiomics analysis for differentiation degree and lymphatic node metastasis of extrahepatic cholangiocarcinoma. BMC Cancer. 2021;21(1):1268.CrossRefPubMedPubMedCentral
17.
go back to reference Qin H, Hu X, Zhang J, Dai H, He Y, Zhao Z, et al. Machine-learning radiomics to predict early recurrence in perihilar cholangiocarcinoma after curative resection. Liver Int. 2021;41(4):837-50.CrossRefPubMed Qin H, Hu X, Zhang J, Dai H, He Y, Zhao Z, et al. Machine-learning radiomics to predict early recurrence in perihilar cholangiocarcinoma after curative resection. Liver Int. 2021;41(4):837-50.CrossRefPubMed
18.
go back to reference Xue B, Wu S, Zhang M, Hong J, Liu B, Xu N, et al. A radiomic-based model of different contrast-enhanced CT phase for differentiate intrahepatic cholangiocarcinoma from inflammatory mass with hepatolithiasis. Abdom Radiol (NY). 2021;46(8):3835-44.CrossRefPubMed Xue B, Wu S, Zhang M, Hong J, Liu B, Xu N, et al. A radiomic-based model of different contrast-enhanced CT phase for differentiate intrahepatic cholangiocarcinoma from inflammatory mass with hepatolithiasis. Abdom Radiol (NY). 2021;46(8):3835-44.CrossRefPubMed
20.
go back to reference Sadamoto Y, Kubo H, Harada N, Tanaka M, Eguchi T, Nawata H. Preoperative diagnosis and staging of gallbladder carcinoma by EUS. Gastrointest Endosc. 2003;58(4):536-41.CrossRefPubMed Sadamoto Y, Kubo H, Harada N, Tanaka M, Eguchi T, Nawata H. Preoperative diagnosis and staging of gallbladder carcinoma by EUS. Gastrointest Endosc. 2003;58(4):536-41.CrossRefPubMed
21.
go back to reference Sugimoto M, Irie H, Takasumi M, Hashimoto M, Oka Y, Takagi T, et al. A simple method for diagnosing gallbladder malignant tumors with subserosa invasion by endoscopic ultrasonography. BMC Cancer. 2021;21(1):288.CrossRefPubMedPubMedCentral Sugimoto M, Irie H, Takasumi M, Hashimoto M, Oka Y, Takagi T, et al. A simple method for diagnosing gallbladder malignant tumors with subserosa invasion by endoscopic ultrasonography. BMC Cancer. 2021;21(1):288.CrossRefPubMedPubMedCentral
22.
go back to reference Hwang J, Kim YK, Choi D, Rhim H, Lee WJ, Hong SS, et al. Gadoxetic acid-enhanced MRI for T-staging of gallbladder carcinoma: emphasis on liver invasion. Br J Radiol. 2014;87(1033):20130608.CrossRefPubMed Hwang J, Kim YK, Choi D, Rhim H, Lee WJ, Hong SS, et al. Gadoxetic acid-enhanced MRI for T-staging of gallbladder carcinoma: emphasis on liver invasion. Br J Radiol. 2014;87(1033):20130608.CrossRefPubMed
23.
go back to reference Kim SJ, Lee JM, Lee JY, Choi JY, Kim SH, Han JK, et al. Accuracy of preoperative T-staging of gallbladder carcinoma using MDCT. AJR Am J Roentgenol. 2008;190(1):74-80.CrossRefPubMed Kim SJ, Lee JM, Lee JY, Choi JY, Kim SH, Han JK, et al. Accuracy of preoperative T-staging of gallbladder carcinoma using MDCT. AJR Am J Roentgenol. 2008;190(1):74-80.CrossRefPubMed
24.
go back to reference Kwon YJ, Song KD, Ko SE, Hwang JA, Kim M. Diagnostic performance and inter-observer variability to differentiate between T1- and T2-stage gallbladder cancers using multi-detector row CT. Abdom Radiol (NY). 2022;47(4):1341-50.CrossRefPubMed Kwon YJ, Song KD, Ko SE, Hwang JA, Kim M. Diagnostic performance and inter-observer variability to differentiate between T1- and T2-stage gallbladder cancers using multi-detector row CT. Abdom Radiol (NY). 2022;47(4):1341-50.CrossRefPubMed
25.
go back to reference Liu Z, Wang S, Dong D, Wei J, Fang C, Zhou X, et al. The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges. Theranostics. 2019;9(5):1303-22.CrossRefPubMedPubMedCentral Liu Z, Wang S, Dong D, Wei J, Fang C, Zhou X, et al. The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges. Theranostics. 2019;9(5):1303-22.CrossRefPubMedPubMedCentral
26.
go back to reference King MJ, Hectors S, Lee KM, Omidele O, Babb JS, Schwartz M, et al. Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features. Cancer Imaging. 2020;20(1):43.CrossRefPubMedPubMedCentral King MJ, Hectors S, Lee KM, Omidele O, Babb JS, Schwartz M, et al. Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features. Cancer Imaging. 2020;20(1):43.CrossRefPubMedPubMedCentral
27.
go back to reference Yang C, Huang M, Li S, Chen J, Yang Y, Qin N, et al. Radiomics model of magnetic resonance imaging for predicting pathological grading and lymph node metastases of extrahepatic cholangiocarcinoma. Cancer Lett. 2020;470:1-7.CrossRefPubMed Yang C, Huang M, Li S, Chen J, Yang Y, Qin N, et al. Radiomics model of magnetic resonance imaging for predicting pathological grading and lymph node metastases of extrahepatic cholangiocarcinoma. Cancer Lett. 2020;470:1-7.CrossRefPubMed
28.
go back to reference Park HJ, Park B, Park SY, Choi SH, Rhee H, Park JH, et al. Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features. Eur Radiol. 2021;31(11):8638-48.CrossRefPubMed Park HJ, Park B, Park SY, Choi SH, Rhee H, Park JH, et al. Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features. Eur Radiol. 2021;31(11):8638-48.CrossRefPubMed
29.
go back to reference Lewis S, Peti S, Hectors SJ, King M, Rosen A, Kamath A, et al. Volumetric quantitative histogram analysis using diffusion-weighted magnetic resonance imaging to differentiate HCC from other primary liver cancers. Abdom Radiol (NY). 2019;44(3):912-22.CrossRefPubMed Lewis S, Peti S, Hectors SJ, King M, Rosen A, Kamath A, et al. Volumetric quantitative histogram analysis using diffusion-weighted magnetic resonance imaging to differentiate HCC from other primary liver cancers. Abdom Radiol (NY). 2019;44(3):912-22.CrossRefPubMed
30.
go back to reference Liu Z, Zhu G, Jiang X, Zhao Y, Zeng H, Jing J, et al. Survival Prediction in Gallbladder Cancer Using CT Based Machine Learning. Front Oncol. 2020;10:604288.CrossRefPubMedPubMedCentral Liu Z, Zhu G, Jiang X, Zhao Y, Zeng H, Jing J, et al. Survival Prediction in Gallbladder Cancer Using CT Based Machine Learning. Front Oncol. 2020;10:604288.CrossRefPubMedPubMedCentral
31.
go back to reference Choi TW, Kim JH, Park SJ, Ahn SJ, Joo I, Han JK. Risk stratification of gallbladder polyps larger than 10 mm using high-resolution ultrasonography and texture analysis. Eur Radiol. 2018;28(1):196-205.CrossRefPubMed Choi TW, Kim JH, Park SJ, Ahn SJ, Joo I, Han JK. Risk stratification of gallbladder polyps larger than 10 mm using high-resolution ultrasonography and texture analysis. Eur Radiol. 2018;28(1):196-205.CrossRefPubMed
32.
go back to reference Gupta P, Rana P, Ganeshan B, Kalage D, Irrinki S, Gupta V, et al. Computed tomography texture-based radiomics analysis in gallbladder cancer: initial experience. Clin Exp Hepatol. 2021;7(4):406-14.CrossRefPubMedPubMedCentral Gupta P, Rana P, Ganeshan B, Kalage D, Irrinki S, Gupta V, et al. Computed tomography texture-based radiomics analysis in gallbladder cancer: initial experience. Clin Exp Hepatol. 2021;7(4):406-14.CrossRefPubMedPubMedCentral
33.
go back to reference Wang L, Zhang Y, Chen Y, Tan J, Wang L, Zhang J, et al. The Performance of a Dual-Energy CT Derived Radiomics Model in Differentiating Serosal Invasion for Advanced Gastric Cancer Patients After Neoadjuvant Chemotherapy: Iodine Map Combined With 120-kV Equivalent Mixed Images. Front Oncol. 2020;10:562945.CrossRefPubMed Wang L, Zhang Y, Chen Y, Tan J, Wang L, Zhang J, et al. The Performance of a Dual-Energy CT Derived Radiomics Model in Differentiating Serosal Invasion for Advanced Gastric Cancer Patients After Neoadjuvant Chemotherapy: Iodine Map Combined With 120-kV Equivalent Mixed Images. Front Oncol. 2020;10:562945.CrossRefPubMed
34.
go back to reference Ma W, Li W, Wang J, Wu R, Liu C, Feng F, et al. The Clinical Role of Preoperative Serum CA19-9 and Carcinoembryonic Antigen (CEA) Levels in Evaluating the Resectability of Advanced Gallbladder Cancer. Med Sci Monit. 2020;26:e925017.CrossRefPubMedPubMedCentral Ma W, Li W, Wang J, Wu R, Liu C, Feng F, et al. The Clinical Role of Preoperative Serum CA19-9 and Carcinoembryonic Antigen (CEA) Levels in Evaluating the Resectability of Advanced Gallbladder Cancer. Med Sci Monit. 2020;26:e925017.CrossRefPubMedPubMedCentral
35.
go back to reference Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, et al. Surgical Indication for Advanced Gallbladder Cancer Considering the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value. Dig Surg. 2020;37(5):390-400.CrossRefPubMed Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, et al. Surgical Indication for Advanced Gallbladder Cancer Considering the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value. Dig Surg. 2020;37(5):390-400.CrossRefPubMed
36.
go back to reference Chen Z, Liu Z, Zhang Y, Wang P, Gao H. Combination of CA19-9 and the Neutrophil-to-Lymphocyte Ratio for the Differential Diagnosis of Gallbladder Carcinoma. Cancer Manag Res. 2020;12:4475-82.CrossRefPubMedPubMedCentral Chen Z, Liu Z, Zhang Y, Wang P, Gao H. Combination of CA19-9 and the Neutrophil-to-Lymphocyte Ratio for the Differential Diagnosis of Gallbladder Carcinoma. Cancer Manag Res. 2020;12:4475-82.CrossRefPubMedPubMedCentral
Metadata
Title
Radiomics-based machine learning and deep learning to predict serosal involvement in gallbladder cancer
Authors
Shengnan Zhou
Shaoqi Han
Weijie Chen
Xuesong Bai
Weidong Pan
Xianlin Han
Xiaodong He
Publication date
03-10-2023
Publisher
Springer US
Published in
Abdominal Radiology / Issue 1/2024
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-023-04029-2

Other articles of this Issue 1/2024

Abdominal Radiology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine